An INRS research team has identified a new family of enzymes that can make precise cuts in single-stranded DNA. A few years ...

The Food and Drug Administration has approved the world’s first medicine based on CRISPR gene-editing technology, a ...

Learn more about whether CRISPR Therapeutics AG or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ ...

Latest study leverages new constructs for nuclear localization signal (NLS) sequences to improve editing efficiency in human immune cells.

A Nature analysis reveals the 25 highest-cited papers published this century and explores why they are breaking records.

What are NGTs, how do they differ from GMOs and how are they agriculturally applied and regulated in the EU?View on euronews ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who also ...

Parkinson's disease is the second most common neurodegenerative disease in the world... | Genetics And Genomics ...

Another reason for choosing a particular modality is that it is a team’s specialty. Strategic choices can be less about ...

From STAT’s Matthew Herper: Pfizer said this morning that it would stop development of danuglipron, its experimental oral GLP-1 medicine to treat obesity, focusing its efforts on another medicine with ...

NPR's Ailsa Chang speaks with Dr. Donald Ingber of the Wyss Institute at Harvard University, about the impact of the stop-work orders that went out this week for federally-funded research.